• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用大隐静脉移植物进行冠状动脉搭桥手术后重复冠状动脉搭桥或冠状动脉血管成形术的频率。

Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts.

作者信息

Weintraub W S, Jones E L, Craver J M, Guyton R A

机构信息

Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia.

出版信息

Am J Cardiol. 1994 Jan 15;73(2):103-12. doi: 10.1016/0002-9149(94)90198-8.

DOI:10.1016/0002-9149(94)90198-8
PMID:8296729
Abstract

This study examines the long-term frequency of reoperative coronary artery bypass grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA) after CABG. The source of data was the clinical database at Emory University Hospitals. The population comprised 3,480 patients undergoing a first CABG between 1978 and 1981. Event-free survival was determined using the Kaplan-Meier method and determinants of survival with the Cox proportional-hazards model. The in-hospital mortality was 1.0% and 5-, 10- and 12-year survival was 91, 78 and 70%. The 5-, 10- and 12-year freedom from reoperative CABG was 98, 88 and 80%. The 5-, 10- and 12-year freedom from PTCA was 98, 91 and 85%. The 5-, 10- and 12-year freedom from either CABG or PTCA was 96, 81 and 69%. Younger patients had much higher incidences of repeat procedures. The yearly incidence of repeat procedures accelerated over time. These data reveal the ultimately palliative nature of revascularization for coronary artery disease.

摘要

本研究调查了冠状动脉旁路移植术(CABG)术后再次行冠状动脉旁路移植术及经皮腔内冠状动脉成形术(PTCA)的长期发生率。数据来源于埃默里大学医院的临床数据库。研究对象为1978年至1981年间接受首次冠状动脉旁路移植术的3480例患者。采用Kaplan-Meier法确定无事件生存率,并使用Cox比例风险模型确定生存的决定因素。住院死亡率为1.0%,5年、10年和12年生存率分别为91%、78%和70%。5年、10年和12年免于再次冠状动脉旁路移植术的比例分别为98%、88%和80%。5年、10年和12年免于经皮腔内冠状动脉成形术的比例分别为98%、91%和85%。5年、10年和12年免于冠状动脉旁路移植术或经皮腔内冠状动脉成形术的比例分别为96%、81%和69%。年轻患者再次手术的发生率要高得多。再次手术的年发生率随时间加速上升。这些数据揭示了冠状动脉疾病血运重建最终的姑息性质。

相似文献

1
Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts.使用大隐静脉移植物进行冠状动脉搭桥手术后重复冠状动脉搭桥或冠状动脉血管成形术的频率。
Am J Cardiol. 1994 Jan 15;73(2):103-12. doi: 10.1016/0002-9149(94)90198-8.
2
Coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. Twenty-year clinical outcome.冠状动脉旁路移植术和经皮腔内冠状动脉成形术。20年临床结果。
Eur Heart J. 2002 Apr;23(7):543-9. doi: 10.1053/euhj.2001.2821.
3
Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease.多支血管病变患者冠状动脉搭桥手术与血管成形术的比较。
N Engl J Med. 1996 Jul 25;335(4):217-25. doi: 10.1056/NEJM199607253350401.
4
Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery.
Circulation. 1997 Feb 18;95(4):868-77. doi: 10.1161/01.cir.95.4.868.
5
Outcomes following coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in the stent era: a prospective study of all 9890 consecutive patients operated on in Scotland over a two year period.支架时代冠状动脉旁路移植术和经皮腔内冠状动脉成形术后的结果:对苏格兰两年内连续接受手术的9890例患者的前瞻性研究。
Heart. 2001 Jun;85(6):662-6. doi: 10.1136/heart.85.6.662.
6
Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status.根据治疗方法和糖尿病状态,对旁路血管成形术血运重建研究(BARI)的七年随访结果。
J Am Coll Cardiol. 2000 Apr;35(5):1122-9. doi: 10.1016/s0735-1097(00)00533-7.
7
Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty.冠状动脉疾病治疗方法的持续演变。冠状动脉成形术时代的初步结果。
Circulation. 1994 May;89(5):2015-25. doi: 10.1161/01.cir.89.5.2015.
8
Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery.冠状动脉成形术与再次冠状动脉旁路移植术用于曾接受旁路手术的患者
J Am Coll Cardiol. 1996 Nov 1;28(5):1140-6. doi: 10.1016/S0735-1097(96)00286-0.
9
[Long-term results in 1,400 patients with coronary artery bypass grafting: saphenous vein vs arterial grafts].1400例冠状动脉旁路移植术患者的长期结果:大隐静脉与动脉移植物对比
Kyobu Geka. 1992 Jul;45(8 Suppl):660-4.
10
Outcome five years after percutaneous transluminal coronary angioplasty or coronary artery bypass grafting for significant narrowing limited to the left anterior descending coronary artery.经皮腔内冠状动脉成形术或冠状动脉旁路移植术后五年的结果,针对仅局限于左前降支冠状动脉的严重狭窄情况。
Am J Cardiol. 1994 Sep 15;74(6):544-9. doi: 10.1016/0002-9149(94)90741-2.

引用本文的文献

1
Comparative efficacy and safety of no-touch versus conventional vein harvesting techniques in coronary artery bypass grafting: a systematic review and meta-analysis.冠状动脉搭桥术中非接触式与传统静脉采集技术的疗效和安全性比较:系统评价与荟萃分析
Open Heart. 2025 Jul 21;12(2):e003391. doi: 10.1136/openhrt-2025-003391.
2
Transmyocardial revascularization (TMR): current status and future directions.经心肌血运重建术(TMR):现状与未来方向。
Indian J Thorac Cardiovasc Surg. 2018 Dec;34(Suppl 3):330-339. doi: 10.1007/s12055-018-0702-7. Epub 2018 Oct 8.
3
Trends in Reoperative Coronary Artery Bypass Graft Surgery for Older Adults in the United States, 1998 to 2017.
1998 年至 2017 年美国老年患者再次冠状动脉旁路移植术的趋势。
J Am Heart Assoc. 2020 Oct 20;9(20):e016980. doi: 10.1161/JAHA.120.016980. Epub 2020 Oct 13.
4
Differences in Expression of Genes Involved in Bone Development and Morphogenesis in the Walls of Internal Thoracic Artery and Saphenous Vein Conduits May Provide Markers Useful for Evaluation Graft Patency.基因表达的差异参与了骨发育和形态发生在内部胸动脉和隐静脉移植物的壁可能提供标记物有用的评估移植物通畅性。
Int J Mol Sci. 2019 Oct 2;20(19):4890. doi: 10.3390/ijms20194890.
5
Spontaneous Resolution of Catheter-Induced Iatrogenic Vein Graft Dissection: First Case Report and Review of Literature.导管诱导性医源性静脉移植物夹层的自发消退:首例病例报告及文献综述
Int J Angiol. 2016 Dec;25(5):e123-e125. doi: 10.1055/s-0035-1546437. Epub 2015 Mar 23.
6
Processing Techniques and Applications of Silk Hydrogels in Bioengineering.丝水凝胶在生物工程中的加工技术与应用
J Funct Biomater. 2016 Sep 14;7(3):26. doi: 10.3390/jfb7030026.
7
Utilization of Pulsatile flow to Decellularize the Human Umbilical Arteries to Make Small-Caliber Blood Vessel Scaffolds.利用脉动流使人类脐动脉去细胞化以制造小口径血管支架。
Acta Cardiol Sin. 2013 Sep;29(5):451-6.
8
Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS).既往有冠状动脉旁路移植术的非ST段抬高型急性冠状动脉综合征患者的非侵入性与侵入性治疗:试点随机对照试验和注册研究(CABG-ACS)的研究设计
Open Heart. 2016 Apr 20;3(1):e000371. doi: 10.1136/openhrt-2015-000371. eCollection 2016.
9
In Vivo Functional Evaluation of Tissue-Engineered Vascular Grafts Fabricated Using Human Adipose-Derived Stem Cells from High Cardiovascular Risk Populations.使用来自高心血管疾病风险人群的人脂肪干细胞制造的组织工程血管移植物的体内功能评估
Tissue Eng Part A. 2016 May;22(9-10):765-75. doi: 10.1089/ten.TEA.2015.0379.
10
Percutaneous coronary intervention strategies and prognosis for graft lesions following coronary artery bypass grafting.冠状动脉旁路移植术后移植血管病变的经皮冠状动脉介入治疗策略及预后
Exp Ther Med. 2015 May;9(5):1656-1664. doi: 10.3892/etm.2015.2366. Epub 2015 Mar 16.